Literature DB >> 24479653

Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.

Xiuhua Zhao1, Weiguo Wang, Yuangang Zu, Ying Zhang, Yong Li, Wei Sun, Chang Shan, Yunlong Ge.   

Abstract

Abstract Betulin, a kind of small molecular compound, was reported that has hypoglycemic effect. Due to its low aqueous solubility and high permeability, betulin has low and variable oral bioavailability. In this work, betulin nanoparticles were thus prepared by antisolvent precipitation for accelerating dissolution of this kind of poorly water-soluble drugs. Ethanol was used as solvent and deionized water was used as antisolvent. The effects of various experimental parameters on the mean particle size (MPS) of nanocrystallization betulin were investigated. The MPS of betulin nanoparticles suspension basically remain unchanged when precipitation time was within 60 min and then increased from 304 nm to 505 nm later. However, the MPS of betulin nanoparticles suspension decreased with increased betulin solution concentration. On the contrary, the MPS of betulin nanoparticles suspension decreased along with the increase of temperature. Stirring intensity and the speed ratio of solvent adding into antisolvent had no significant influences on the MPS of betulin nanoparticles suspension. Betulin nanoparticles suspension with a MPS of approximately 110 nm was achieved under the optimal precipitation conditions. FTIR, Liquid chromatography coupled with tandem mass spectrometry (LC-MS), X-ray diffraction (XRD), differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) were used to analyze the characteristic of betulin nanoparticles powder. These results show that betulin nanoparticles powder has the same chemical structure as raw drug, but a smaller size and lower crystallinity. The dissolution rate and solubility of betulin nanoparticles powder were separately 3.12 and 1.54 times of raw drug. The bioavailability of betulin nanoparticles powder increased 1.21 times compared with raw betulin. The result of in vivo evaluation on diabetic animals demonstrates that the betulin nanoparticles powder show an excellent hypoglycemic effect compared with raw betulin. In addition, the residual ethanol is less than the ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human) limit for class 3 solvents of 5000 ppm or 0.5% for solvents.

Entities:  

Keywords:  Absorption enhancer; bioavailability; in vitro/in vivo correlations; nanotechnology; oral absorption

Mesh:

Substances:

Year:  2014        PMID: 24479653     DOI: 10.3109/10717544.2014.881438

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  10 in total

Review 1.  Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives.

Authors:  Rahul Kumar; Amit K Thakur; Nilanjana Banerjee; Ashutosh Kumar; Gajendra Kumar Gaurav; Raj Kumar Arya
Journal:  Drug Deliv Transl Res       Date:  2022-08-11       Impact factor: 5.671

2.  Antioxidative Activity Evaluation of High Purity and Micronized Tartary Buckwheat Flavonoids Prepared by Antisolvent Recrystallization.

Authors:  Yanjie Liu; Xiaoyu Sui; Xiuhua Zhao; Siying Wang; Qilei Yang
Journal:  Foods       Date:  2022-05-05

3.  A novel albumin wrapped nanosuspension of meloxicam to improve inflammation-targeting effects.

Authors:  Qi Li; Fen Chen; Yun Liu; Shihui Yu; Xiumei Gai; Mingzhu Ye; Xinggang Yang; Weisan Pan
Journal:  Int J Nanomedicine       Date:  2018-08-15

Review 4.  Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds.

Authors:  Xin Nie; Zhejie Chen; Lan Pang; Lin Wang; Huajuan Jiang; Yi Chen; Zhen Zhang; Chaomei Fu; Bo Ren; Jinming Zhang
Journal:  Int J Nanomedicine       Date:  2020-12-16

5.  Overexpression of ABCC1 Confers Drug Resistance to Betulin.

Authors:  Xuan-Yu Chen; Yuqi Yang; Jing-Quan Wang; Zhuo-Xun Wu; Jing Li; Zhe-Sheng Chen
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 6.  Anti-Diabetic Potential of Plant-Based Pentacyclic Triterpene Derivatives: Progress Made to Improve Efficacy and Bioavailability.

Authors:  Michael Oboh; Laurencia Govender; Muthulisi Siwela; Blessing Nkazimulo Mkhwanazi
Journal:  Molecules       Date:  2021-11-29       Impact factor: 4.411

7.  Novel polymeric derivatives of betulin with anticancer activity.

Authors:  Daria Niewolik; Katarzyna Krukiewicz; Barbara Bednarczyk-Cwynar; Piotr Ruszkowski; Katarzyna Jaszcz
Journal:  RSC Adv       Date:  2019-07-04       Impact factor: 4.036

Review 8.  Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy.

Authors:  Saikat Dewanjee; Pratik Chakraborty; Biswajit Mukherjee; Vincenzo De Feo
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

Review 9.  Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases.

Authors:  J P Jose Merlin; Xiaogang Li
Journal:  Front Genet       Date:  2022-01-05       Impact factor: 4.599

10.  Preparation and Characterization of Electrospun Polylactic Acid (PLA) Fiber Loaded with Birch Bark Triterpene Extract for Wound Dressing.

Authors:  Tianyuan Fan; Rolf Daniels
Journal:  AAPS PharmSciTech       Date:  2021-07-20       Impact factor: 3.246

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.